Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer Research

• Publication date

  1994-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8205528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

  1994cited by this paper
• Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

  1994cited by this paper
• Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

  1994influential reference
• Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes

  1994influential reference
• Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens.

  1993cited by this paper
• The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1993cited by this paper
• Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

  1992cited by this paper
• Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment.

  1991cited by this paper
• Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation.

  1991cited by this paper
• A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

  1991cited by this paper
• Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes.

  1990cited by this paper
• Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification.

  1990cited by this paper
• The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins.

  1989cited by this paper
• Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.

  1989cited by this paper
• Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA

  1989cited by this paper
• Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

  1988cited by this paper
• Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.

  1987cited by this paper
• In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

  1987cited by this paper
• A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

  1986cited by this paper
• H-2 restriction of adoptive immunotherapy of advanced tumors.

  1981cited by this paper

• Alternative splicing: from tumorigenesis to neoantigen-mediated cancer immunotherapy

  2025cites this paper
• Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing

  2024cites this paper
• Neoantigens: promising targets for cancer therapy

  2023cites this paper
• InvitroSPI and a large database of proteasome-generated spliced and non-spliced peptides

  2023cites this paper
• Database search engines and target database features impinge upon the identification of post‐translationally cis‐spliced peptides in HLA class I immunopeptidomes

  2022cites this paper
• Neo-Splicetopes in Tumor Therapy: A Lost Case?

  2022cites this paper
• Navigating Critical Challenges Associated with Immunopeptidomics-Based Detection of Proteasomal Spliced Peptide Candidates.

  2022cites this paper
• An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool

  2022cites this paper
• A Case of Amelanotic Melanoma in the Setting of Cemiplimab Therapy for Invasive Squamous Cell Carcinoma

  2022cites this paper
• Tyrosinase suppresses vasculogenic mimicry in human melanoma cells

  2022cites this paper
• Neoantigen-Specific T Cells in Adoptive Cell Therapy.

  2022cites this paper
• New Insights into the Mechanisms of Proteasome-Mediated Peptide Splicing Learned from Comparing Splicing Efficiency by Different Proteasome Subtypes

  2022cites this paper
• Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

  2021cites this paper
• Commentary: Are There Indeed Spliced Peptides in the Immunopeptidome?

  2021cites this paper
• Mechanistic diversity in MHC class I antigen recognition

  2021cites this paper
• Proteasome-Generated cis-Spliced Peptides and Their Potential Role in CD8+ T Cell Tolerance

  2021cites this paper
• In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo

  2021cites this paper
• What We See, What We Do Not See, and What We Do Not Want to See in HLA Class I Immunopeptidomes

  2020cites this paper
• Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma

  2020cites this paper
• Large database for the analysis and prediction of spliced and non-spliced peptide generation by proteasomes

  2020cites this paper
• An in silico—in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

  2019cites this paper
• Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

  2019cites this paper
• 13 – Cancer Vaccines

  2018cites this paper
• Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma.

  2018cites this paper
• Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.

  2017cites this paper
• Post-Translational Peptide Splicing and T Cell Responses.

  2017cites this paper
• Role of cell based approaches in cancer immunotherapy

  2017cites this paper
• Post-translational peptide splicing and T cell response

  2017cites this paper
• Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.

  2017cites this paper
• Epitope located N‐glycans impair the MHC‐I epitope generation and presentation

  2016cites this paper
• Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes

  2016cites this paper
• The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti–PD-1 Response in Patients with Renal Cell Carcinoma

  2016cites this paper
• Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.

  2015cites this paper
• Tumor‐infiltrating lymphocytes for the treatment of metastatic cancer

  2015cites this paper
• Cancer vaccines

  2015cites this paper
• Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines

  2013cites this paper
• Recent advances in design of immunogenic and effective naked DNA vaccines against cancer.

  2013cites this paper
• Characterization of T-cell Receptors Directed Against HLA-A*01-restricted and C*07-restricted Epitopes of MAGE-A3 and MAGE-A12

  2012cites this paper
• Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity

  2012cites this paper
• Harnessing DNA-induced immune responses for improving cancer vaccines

  2012cites this paper
• Dendritic Cell-Based Cancer Vaccines: Practical Considerations

  2011cites this paper
• An antigenic peptide produced by reverse splicing and double asparagine deamidation

  2011cites this paper
• DNA Vaccines: Developing New Strategies against Cancer

  2010cites this paper
• Targeting Tyrosinase Engineered with a Highly Avid TCR Effective In Vivo Tumor Treatment When Both CD4 and CD8 T Cells Mediate Equally

  2010cites this paper
• Vaccinia virus expressing ICP47 : a novel platform for cancer vaccines highlighting tumor epitopes and hiding viral antigens

  2010cites this paper
• Both CD4 and CD8 T Cells Mediate Equally Effective In Vivo Tumor Treatment When Engineered with a Highly Avid TCR Targeting Tyrosinase

  2010cites this paper
• Molecular Cloning and Characterization of MHC Class I– and II–Restricted Tumor Antigens Recognized by T Cells

  2009cites this paper
• Targeting the immune system in cancer.

  2009cites this paper
• New perspectives for melanoma immunotherapy: role of IL-12.

  2009cites this paper
• This information is current as Cell Functions TCR CDRs Can Enhance Antigen-Specific T Single and Dual Amino Acid Substitutions in and

  2008cites this paper
• AUGMENTATION OF T CELL EXPANSION FOR ADOPTIVE IMMUNOTHERAPY BY ALTERNATE GAMMA CHAIN CYTOKINES AND BY GEMCITABINE MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS

  2008cites this paper
• Identification of Metastasis Associated Antigen 1 (MTA1) by Serological Screening of Prostate Cancer cDNA Libraries

  2008cites this paper
• Allogeneic Melanoma Vaccine Expressing αGal Epitopes Induces Antitumor Immunity to Autologous Antigens in Mice Without Signs of Toxicity

  2008cites this paper
• Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

  2008cites this paper
• Cancer vaccines: accomplishments and challenges.

  2008cites this paper
• Interleukin-15 and [alpha](1,3)galactosyl-expressing vaccine combination therapy for melanoma

  2007cites this paper
• Identification of an overexpressed gene, HSPA4L, the product of which can provoke prevalent humoral immune responses in leukemia patients.

  2007cites this paper
• Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients

  2007cites this paper
• Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2′-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications

  2007cites this paper
• Adoptive T-cell therapy of cancer.

  2006cites this paper
• Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma

  2006cites this paper
• DNA Immunization against Tissue-Restricted Antigens Enhances Tumor Immunity after Allogeneic Hemopoietic Stem Cell Transplantation1

  2006cites this paper
• TransplantationAllogeneic Hemopoietic Stem Cell Antigens Enhances Tumor Immunity after DNA Immunization against Tissue-Restricted

  2006cites this paper
• Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells.

  2006cites this paper
• Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell–Mediated Patient-Specific Immunotherapy

  2006cites this paper
• Tumor antigens and tumor antigen discovery.

  2005cites this paper
• The TLR7 Agonist Imiquimod Enhances the Anti-Melanoma Effects of a Recombinant Listeria monocytogenes Vaccine1

  2005cites this paper
• Listeria monocytogenes Anti-Melanoma Effects of a Recombinant The TLR 7 Agonist Imiquimod Enhances the Prins

  2005cites this paper
• Vaccine Immunotherapy for a Deadly Disease Like Malignant Melanoma: Where Do We Stand?*

  2005cites this paper
• Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.

  2005cites this paper
• Melanoma immunotherapy: past, present, and future.

  2005cites this paper
• Genetic Vaccines and Therapy

  2005cites this paper
• Clinical trial design and regulatory issues for therapeutic cancer vaccines.

  2005cites this paper
• Polarized Dendritic Cells for Tumor Immunotherapy

  2005cites this paper
• Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2.

  2005cites this paper
• MHC ligands and peptide motifs: first listing

  2004cites this paper
• Cytolytic T lymphocyte responses of cancer patients to tumor-associated antigens

  2004cites this paper
• Direct identification of tumor-associated peptide antigens

  2004cites this paper
• Immune responses against spontaneous tumors in a murine model for pancreatic adenocarcinoma

  2004cites this paper
• Lentivirus Vector-Mediated Expression of Tumor-Associated Epitopes by Human Antigen Presenting Cells

  2004influential citation
• Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients

  2004cites this paper
• Thymus‐leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor‐specific antigen

  2004cites this paper
• Identification of Tumor Antigens Using Subtraction and Microarrays

  2004cites this paper
• Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen

  2004cites this paper
• Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.

  2004cites this paper
• Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma

  2004cites this paper
• Identification of human tumor antigens and its implications for diagnosis and treatment of cancer

  2004cites this paper
• P704P, P712P, and P775P: A genomic cluster of prostate‐specific genes

  2004cites this paper
• Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer

  2004cites this paper
• CTL-defined Cancer Vaccines: Perspectives for Active Immunotherapeutic Interventions in Minimal Residual Disease

  2004cites this paper
• Melanoma vaccines: early progress and future promises.

  2003cites this paper
• Human melanoma antigens recognized by CD8+ T cells

  2003cites this paper
• Frequenzanalyse und Charakterisierung Antigen-spezifischer T-Zellen bei Melanompatienten unter Immuntherapie

  2003influential citation
• A Mutated f 3-Catenin Gene Encodes a Melanoma-spec

  2003cites this paper
• Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice

  2003cites this paper
• Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.

  2003cites this paper
• Genetic Vaccines and Therapy

  2003cites this paper
• Effects of granulocyte‐macrophage colony‐stimulating factor and foreign helper protein as immunologic adjuvants on the T‐cell response to vaccination with tyrosinase peptides

  2003cites this paper
• Patient with Melanoma Tumor-Infiltrating Lymphocytes from a Differentiation Antigens Are Recognized by Multiple HLA Class II-Restricted Melanocyte

  2002cites this paper
• Pharmaceutical biotechnology

  2002cites this paper